13F-HR filed by Birchview Capital, LP
Birchview Capital, LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 73 holding rows worth $175,663,720.
- Accession
- 0001618205-26-000002
- Filer
- CIK 1618205
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 73 entries on the cover page, a total value of $175,663,720 stated on the cover page (in dollars after the unit check, H1), rows summing to $175,663,720 with VALUE read as dollars as filed, 13F file number 028-16416. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KLA CORP | 482480100 | COM | 19,883 | $29,275,928 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 306,268 | $18,575,154 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,465,867 | $7,754,436 | dollars as filed | |
| Lam Research Corporation | 512807306 | COM | 36,000 | $7,691,760 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 210,000 | $6,837,600 | dollars as filed | |
| OVINTIV INC | 69047Q102 | COM | 107,500 | $6,381,200 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 445,400 | $5,710,028 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 100,000 | $4,820,000 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 625,980 | $4,507,056 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 449,019 | $4,364,465 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 286,804 | $4,158,657 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 171,000 | $3,806,460 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 35,000 | $3,689,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 27,190 | $3,582,011 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 219,000 | $3,265,290 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 409,387 | $2,849,334 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 320,000 | $2,710,400 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 4,500 | $2,668,410 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 31,000 | $2,230,450 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 70,095 | $2,223,413 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 202,330 | $2,205,397 | dollars as filed | |
| EQT CORP COM | 26884L109 | Stock | 34,619 | $2,203,153 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 195,000 | $2,166,450 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 463,599 | $2,151,099 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 375,000 | $2,073,750 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,500,000 | $1,980,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 30,000 | $1,977,300 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 47,200 | $1,902,632 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 44,000 | $1,770,120 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 50,000 | $1,768,000 | dollars as filed | |
| ENGENE HOLDINGS INC | 29286M105 | COM | 250,000 | $1,702,500 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 100,697 | $1,646,396 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 70,000 | $1,368,500 | dollars as filed | |
| QUIDEL CORP | 74838J101 | COM | 82,548 | $1,356,264 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 281,730 | $1,346,669 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 62,000 | $1,298,900 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 21,000 | $1,221,150 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 57,000 | $1,147,410 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 50,000 | $1,093,500 | dollars as filed | |
| FREEPORT MCMORAN INC CL B | 35671D857 | Stock | 18,040 | $1,060,392 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 6,000 | $1,014,120 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 5,000 | $916,650 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 111,786 | $893,170 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 29,200 | $867,532 | dollars as filed | |
| HARROW INC | 415858109 | COM | 24,000 | $846,240 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 29,847 | $843,178 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 150,000 | $795,000 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 9,000 | $757,530 | dollars as filed | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 10,100 | $652,763 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 8,688 | $645,171 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 14,000 | $563,220 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 16,860 | $561,775 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 25,889 | $559,202 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 66,270 | $555,343 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 83,952 | $467,613 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 127,025 | $454,750 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 20,100 | $393,156 | dollars as filed | |
| OUTSET MEDICAL INC | 690145107 | COM | 98,882 | $379,707 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 250,221 | $322,785 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 12,900 | $316,695 | dollars as filed | |
| TRINITY CAP INC | 896442308 | COM | 20,000 | $294,200 | dollars as filed | |
| CANDEL THERAPEUTICS INC | 137404109 | COMMON STOCK | 60,000 | $294,000 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 74,918 | $289,183 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 20,000 | $284,200 | dollars as filed | |
| KAYNE ANDERSON BDC INC | 48662X105 | COM SHS | 20,000 | $274,400 | dollars as filed | |
| GRACE THERAPEUTICS INC | 00439U104 | COM | 50,000 | $231,500 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 165,094 | $173,349 | dollars as filed | |
| KYNTRA BIO INC | 31572Q881 | COM NEW | 22,566 | $152,997 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 20,000 | $132,000 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 14,300 | $119,834 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 17,503 | $40,957 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 39,573 | $24,895 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 18,176 | $5,971 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001618205-26-000002 | this filing | 2026-05-15 | acceptance time not in the bulk data set |